Viewing Study NCT00327418


Ignite Creation Date: 2025-12-25 @ 4:51 AM
Ignite Modification Date: 2026-03-10 @ 12:22 PM
Study NCT ID: NCT00327418
Status: COMPLETED
Last Update Posted: 2007-05-10
First Post: 2006-05-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module